Mike Matson
Stock Analyst at Needham
(3.30)
# 1,009
Out of 5,124 analysts
545
Total ratings
45.02%
Success rate
3.29%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $121 → $97 | $76.27 | +27.18% | 35 | Feb 5, 2026 | |
| AORT Artivion | Reiterates: Buy | $58 | $39.59 | +46.50% | 21 | Feb 2, 2026 | |
| SYK Stryker | Maintains: Buy | $448 → $454 | $358.29 | +26.71% | 11 | Jan 30, 2026 | |
| CNMD CONMED | Reiterates: Hold | n/a | $41.52 | - | 26 | Jan 29, 2026 | |
| TFX Teleflex | Upgrades: Buy | $138 | $108.42 | +27.28% | 10 | Jan 27, 2026 | |
| PEN Penumbra | Downgrades: Hold | n/a | $341.02 | - | 14 | Jan 16, 2026 | |
| NEO NeoGenomics | Reiterates: Buy | $14 | $11.42 | +22.59% | 28 | Jan 12, 2026 | |
| ESTA Establishment Labs Holdings | Reiterates: Buy | $84 | $68.69 | +22.29% | 6 | Jan 12, 2026 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $108 | $82.50 | +30.91% | 32 | Jan 9, 2026 | |
| HAE Haemonetics | Downgrades: Hold | n/a | $59.34 | - | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $148 → $166 | $135.06 | +22.91% | 14 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.22 | +145.90% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.25 → $9 | $7.32 | +22.95% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $8.06 | +24.15% | 21 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $44 | $36.19 | +21.58% | 18 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $26 | $16.65 | +56.16% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $74.81 | - | 22 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $15.08 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $66.56 | -3.85% | 27 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $102.90 | - | 21 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $49 | $22.59 | +116.91% | 16 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $37.11 | +21.26% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $5.65 | +112.39% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $139.15 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $154.16 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $252.16 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $89.91 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $271.63 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $15.60 | +169.32% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $87.81 | -14.59% | 1 | Feb 18, 2021 |
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $121 → $97
Current: $76.27
Upside: +27.18%
Artivion
Feb 2, 2026
Reiterates: Buy
Price Target: $58
Current: $39.59
Upside: +46.50%
Stryker
Jan 30, 2026
Maintains: Buy
Price Target: $448 → $454
Current: $358.29
Upside: +26.71%
CONMED
Jan 29, 2026
Reiterates: Hold
Price Target: n/a
Current: $41.52
Upside: -
Teleflex
Jan 27, 2026
Upgrades: Buy
Price Target: $138
Current: $108.42
Upside: +27.28%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: n/a
Current: $341.02
Upside: -
NeoGenomics
Jan 12, 2026
Reiterates: Buy
Price Target: $14
Current: $11.42
Upside: +22.59%
Establishment Labs Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $84
Current: $68.69
Upside: +22.29%
Merit Medical Systems
Jan 9, 2026
Reiterates: Buy
Price Target: $108
Current: $82.50
Upside: +30.91%
Haemonetics
Dec 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $59.34
Upside: -
Dec 8, 2025
Maintains: Buy
Price Target: $148 → $166
Current: $135.06
Upside: +22.91%
Nov 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.22
Upside: +145.90%
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $7.32
Upside: +22.95%
Nov 5, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $8.06
Upside: +24.15%
Nov 5, 2025
Maintains: Buy
Price Target: $41 → $44
Current: $36.19
Upside: +21.58%
Oct 29, 2025
Maintains: Buy
Price Target: $42 → $26
Current: $16.65
Upside: +56.16%
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $74.81
Upside: -
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $15.08
Upside: -
Sep 3, 2025
Reiterates: Buy
Price Target: $64
Current: $66.56
Upside: -3.85%
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $102.90
Upside: -
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $22.59
Upside: +116.91%
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $37.11
Upside: +21.26%
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $5.65
Upside: +112.39%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $139.15
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $154.16
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $252.16
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $89.91
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $271.63
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $15.60
Upside: +169.32%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $87.81
Upside: -14.59%